Brain grafts and Parkinson's disease.
In animal models, grafts derived from several different tissues, principally fetal substantia nigra and adrenal medulla from young adults, have been found to be effective in alleviating some of the manifestations of lesions of the substantia nigra. It has been suggested that these grafts function by diffusely secreting dopamine, by exerting trophic effects on the host brain, or by producing a new innervation of the host corpus striatum. Evidence for each of these modes of action is briefly reviewed. Several brain tissue transplantation techniques have been described. Each of these techniques has significant limitations in animal models. The significance of these limitations for human application is described, and possibilities for improving the efficacy of brain tissue transplantation in animal models and for human application are discussed.
Freed
W J
WJ
NIMH Neurosciences Center at St. Elizabeths, NIMH Intramural Research Program, Washington, D.C. 20032.
Poltorak
M
M
Takashima
H
H
LaMarca
M E
ME
Ginns
E I
EI
D000313:Adrenal Medulla / Q000637:transplantation; D000818:Animals; D016380:Brain Tissue Transplantation; D016332:Fetal Tissue Transplantation; D005347:Fibroblasts / Q000637:transplantation; D006801:Humans; D008954:Models, Biological; D010300:Parkinson Disease / Q000628:therapy*; D013378:Substantia Nigra / Q000637:transplantation; D014162:Transfection / Q000235:genetics